- Filed
- Apr 23, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 17, 2026 | 52.1M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 51M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 54.8M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $0 |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $500M |
| Capex | Q1 2026 · Mar 31, 2026 | $27M |
| Capex | Q1 2026 · Mar 31, 2025 | $22M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $1.08B |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $190M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $3.77B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $3.77B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $5.31B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $4.25B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $4.86B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $4.08B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $4.07B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $4.31B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $4.5B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $8.19B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $7.37B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $12.31B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $11.5B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $13.33B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $12.44B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $16.39B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $15.56B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.27 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $5.45 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.27 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $5.47 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $779M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $774M |
| Net Income | Q1 2026 · Mar 31, 2026 | $14M |
| Net Income | Q1 2026 · Mar 31, 2025 | $298M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $83M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $433M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $9.27B |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $9.48B |
| Revenue | Q1 2026 · Mar 31, 2026 | $10.8B |
| Revenue | Q1 2026 · Mar 31, 2025 | $11.15B |